Drugs / JWCAR129
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04677452 | Dec 2020 → Mar 2022 | — | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JWCAR129 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04677452 ↗ |
| Modality | Cell therapy | “JWCAR129, a CAR T-cell product that targets B-cell maturation antigen (BCMA)” NCT04677452 ↗ |
| Route | Intravenous | “JWCAR129 administered intravenously (IV)” NCT04677452 ↗ |